Sunday p.m., July 27, 1997
Role of Hormone Metabolism and Oxidative Stress in Breast and Prostate Cancer
Chair: Jonathan Li, Kansas City, Kansas
- James Yager, Baltimore, MD - "Catechol estrogens as mediators of oxidative damage and stress: inactivation by catechol -methyltransferase and the COMT low activity polymorphism as a risk factor for breast cancer."
- Shuk-mei Ho, Boston, MA - "Hormone metabolism and oxidative stress in prostate cancer."
Monday a.m., July 28, 1997
Relevance of Receptor Variants to Hormonal Carcinogenesis
Chair: Kenneth Korach, Research Triangle Park, NC
- Nancy Weigel, Houston, TX - "Steroid receptors, coactivators and phosphorylation"
- Dolores Lamb, Houston, TX - "Androgen receptor mutations in advanced prostate cancer"
- Terry Brown, Baltimore, MD - "Functional properties of mutant androgen receptors"
Monday 4:00-6:00 p.m., July 28, 1997
POSTER SESSION
- Chair: Manfred Metzler, Kaiserslautern, Germany
Monday p.m., July 28, 1997
Regulation of Hormone Receptor Action by Accessory Proteins
Chair: Michael Gallo, Piscataway, NJ
- Geoffrey Greene, Chicago, IL - "Accessory proteins that modulate estrogen receptor function"
- Jan-Ake Gustaffson, Huddinge, Sweden - "Novel insights into the mechanism of action of estrogens in the light of the discovery of a second estrogen receptor gene"
Tuesday a.m., July 29, 1997
Molecular Determinants of Breast Cancer
Chair: Saraswati Sukumar, Baltimore, MD
- Michelle Bennett, Research Triangle Park, NC - "Mouse models for breast cancer susceptibility"
- Carrie Rinker-Schaeffer, Chicago, IL - "The role of metastasis-suppressor genes in malignant progression"
- Jose Russo, Philadelphia, PA - "Molecular basis of human breast cancer"
Tuesday p.m., July 29, 1997
Molecular Determinants of Endometrial Cancer
Chair: Gerald Cunha, San Francisco, CA
- Jeffrey Boyd, Philadelphia, PA - "Molecular mechanism of estrogen-induced human cancers"
- Cheryl Walker, Smithville, TX - "Impact of estrogens and antiestrogens on uterine leiomyoma"
Wednesday a.m., July 30, 1997
Molecular Determinants of Prostate Cancer
Chair: James Norris, Charleston, SC
- Chawnshang Chang, Madison, WI - "From estrogen to androgen: changing sex hormone specificity in the presence of androgen receptor co-activator ARA70"
- Maarten Bosland, Tuxedo, NY - "Do hormones cause prostate cancer and can this be prevented?"
- Nicholas Bruchovsky, British Columbia - "AP-1 and the androgen receptor: factors in the endocrine-related progression of prostate cancer"
Wednesday 4:00-6:00 p.m., July 30, 1997
POSTER SESSION
- Chair: Gail Prins, Chicago, IL
Wednesday p.m., July 30, 1997
Panel Discussion - Do Environmental Hormones Cause Cancer in Humans?
Chair: George Stancel, Houston, TX
- George Lucier, Research Triangle Park, NC
- Jon Cook, Newark, DE
- Mary Wolff, New York, NY
Thursday a.m., July 31, 1997
Prevention of Hormonally-Mediated Cancer
Chair: Leland Chung, Charlottesville, VA
- Angela Brodie, Baltimore, MD - "Aromatase and aromatase inhibitors in breast cancer"
- Christopher Portier, Research Triangle Park,NC - "Modeling the effects of environmental estrogens on cancer rates"
- Coral Lamartiniere, Birmingham, AL - "Programming against breast cancer with genistein, a phytoestrogen component of soy"
- Richard Santen, Charlottesville, VA - "Role of Aromotase in breast tissue estrogen concentration and carcinogenesis"
Thursday p.m., July 31, 1997
Conference Address
- John McLachlan, New Orleans, LA - "Estrogens, development and cancer"
|